Your browser doesn't support javascript.
loading
Switching from blonanserin oral tablets/powders to transdermal patches alleviates extrapyramidal symptoms in patients with schizophrenia: A 52-week open-label study.
Ohi, Kazutaka; Takai, Kentaro; Kuramitsu, Ayumi; Sugiyama, Shunsuke; Shioiri, Toshiki.
Afiliação
  • Ohi K; Department of Psychiatry, Gifu University Graduate School of Medicine, Gifu, Japan; Department of General Internal Medicine, Kanazawa Medical University, Ishikawa, Japan. Electronic address: k_ohi@gifu-u.ac.jp.
  • Takai K; Department of Psychiatry, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Kuramitsu A; Department of Psychiatry, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Sugiyama S; Department of Psychiatry, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Shioiri T; Department of Psychiatry, Gifu University Graduate School of Medicine, Gifu, Japan.
Article em En | MEDLINE | ID: mdl-34740708

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Piperidinas / Pós / Esquizofrenia / Comprimidos / Discinesias / Adesivo Transdérmico Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Prog Neuropsychopharmacol Biol Psychiatry Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Piperidinas / Pós / Esquizofrenia / Comprimidos / Discinesias / Adesivo Transdérmico Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Prog Neuropsychopharmacol Biol Psychiatry Ano de publicação: 2022 Tipo de documento: Article